Philadelphia Business Journal Names Frontage Best CRO!

For the fourth time this year, Frontage has gained recognition for its success in providing contract research services to biotech and pharmaceutical companies.  In October, the company was named one of the Best Contract Research Organization (CRO) in the Philadelphia Business Journal’s 2012 Life Science Awards Program.  The company was selected for the program following an extensive review by an external panel of independent judges.

 

The recent award follows Frontage’s August election to the Inc. Magazine 5000 list of fastest growing private companies, where Frontage placed in the top 300 health care organizations.  The company was also named to the Fast 50 Asian American Business list in June, and Smart CEO Magazine’s Future 50 list published in January.

 

“We are honored to be named Best CRO by the Philadelphia Business Journal,” said Dr. Song Li, CEO and Chairman of Frontage.  “The public recognition this year has been gratifying.  What’s equally exciting is that new and existing clients continue to be satisfied with our work.  Their private comments thanking us for our dependability and attention to detail confirms we are making real progress.”

 

Frontage joins other fast growing life science companies on the Business Journal list, including Inovio Pharmaceuticals, named Best Mid-Stage Product Development Company, and QR Pharma, Inc., Best Early Stage Company.